Details for New Drug Application (NDA): 091544
✉ Email this page to a colleague
The generic ingredient in LITHIUM CARBONATE is lithium carbonate. There are fifteen drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the lithium carbonate profile page.
Summary for 091544
Tradename: | LITHIUM CARBONATE |
Applicant: | Glenmark Pharms Inc |
Ingredient: | lithium carbonate |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 091544
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LITHIUM CARBONATE | lithium carbonate | TABLET, EXTENDED RELEASE;ORAL | 091544 | ANDA | A-S Medication Solutions | 50090-1470 | 50090-1470-0 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50090-1470-0) |
LITHIUM CARBONATE | lithium carbonate | TABLET, EXTENDED RELEASE;ORAL | 091544 | ANDA | Glenmark Pharmaceuticals Inc., USA | 68462-223 | 68462-223-01 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-223-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 300MG | ||||
Approval Date: | Dec 27, 2010 | TE: | AB | RLD: | No |
Complete Access Available with Subscription